Regulatory effects of cyclosporin A and tacrolimus on the immunological gene expressions in renal transplant recipients.
- Author:
Jin WEN
1
;
Zhi-gang JI
;
Ji-rui NIU
Author Information
- Publication Type:Journal Article
- MeSH: Cyclosporine; pharmacology; Cytokines; genetics; metabolism; Gene Expression Regulation; Humans; Kidney; drug effects; metabolism; Kidney Transplantation; Oligonucleotide Array Sequence Analysis; T-Lymphocytes, Helper-Inducer; drug effects; metabolism; Tacrolimus; pharmacology
- From: Acta Academiae Medicinae Sinicae 2012;34(6):563-566
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the change of Th immunological gene in renal transplant recipients after the treatment of cyclosporine (CsA) and tacrolimus (FK506).
METHODSThe peripheral blood lymphacytes just before and 24 hours after CsA and FK506 treatment were isolated. The total RNA of them were reverse-transcripted and examined by real-time quantity PCR array. The results were analyzed by bioinformatic methods.
RESULTSThe TLR4, CEBPB, IL4R, IL1R1,IL18R1,and IL1R2 genes were remarkably upregulated, whereas IL-2, CCL5, CD27, CCR5, CCR4, CD4, RPL13A, TGFB3, CD86, CCR3, STAT1, NFATC2IP, IL23A, IL15, IRF4, and TFCP2 were downregulated 24 hours after CsA treatment. The IL18, IL7, PTPRC, TNFSF4, SPP1, GFI1, TLR4, IL13RA1, TNF, INHBA, LAG3, IL13, IL1R1, SOCS5, IL10, YY1, TBX21, FASLG, IL18R1, and IL1R2 genes were remarkably upregulated, whereas IL-2, IL-3, IL-4, IL-6,CCR5, CD4, CD27, CD40LG, IL15, CCR3, CD86, CCR4, and IRF4 were obviously downregulated 24 hours after FK506 treatment.
CONCLUSIONCsA and FK506 exert their therapeutic effectiveness by regulating the expressions of a series of target genes.
